Suppression of adjuvant disease by bacterial extracellular products.
Open Access
- 1 November 1972
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 31 (6), 500-507
- https://doi.org/10.1136/ard.31.6.500
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Immunosuppression by procarbazine: I. Sites of action of the drug and effect on adjuvant arthritis and circulating antibody responsesCellular Immunology, 1972
- Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the diseaseCellular Immunology, 1972
- DISSOCIATION OF HEMOLYTIC AND LYMPHOCYTE-TRANSFORMING ACTIVITIES OF STREPTOLYSIN S PREPARATIONSThe Journal of Experimental Medicine, 1969
- Suppression of adjuvant arthritis by a new cytotoxic compound, rubidomycin.Annals Of The Rheumatic Diseases, 1969
- Immunosuppressant from Group A StreptococciScience, 1968
- SUPPRESSION OF ADJUVANT DISEASE IN THE RAT BY HETEROLOGOUS ANTILYMPHOCYTE GLOBULINThe Journal of Experimental Medicine, 1968
- Effect of Antilymphocytic Antibody and Antibody Fragments on Human Lymphocytes in vitroNature, 1967
- PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLSThe Journal of Experimental Medicine, 1964
- Passive Transfer of Adjuvant Arthritis in Rats with Living Lymphoid Cells of Sensitized DonorsInternational Archives of Allergy and Immunology, 1963
- Protection of Rats against Adjuvant Arthritis by Bacterial LipopolysaccharidesScience, 1962